The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Organ targeting In vivo using phage display peptide libraries
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
Springer, T. A. (1994) · Cell · doi:10.1016/0092-8674(94)90337-9 · Cited by 6,929
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262
Bevilacqua, M. P., Stengelin, S., Gimbrone, M. A., & Seed, B. (1989) · Science · doi:10.1126/science.2466335 · Cited by 2,005
Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the αEβ7 integrin
Cepek, K. L., Shaw, S. K., Parker, C. M., Russell, G. J., Morrow, J. S., Rimm, D. L., & Brenner, M. B. (1994) · Nature · doi:10.1038/372190a0 · Cited by 1,178
Biological Diversity in Metastatic Neoplasms: Origins and Implications
Fidler, I. J., & Hart, I. R. (1982) · Science · doi:10.1126/science.7112116 · Cited by 928
[15] Libraries of peptides and proteins displayed on filamentous phage
Smith, G. P., & Scott, J. K. (1993) · Methods in Enzymology · doi:10.1016/0076-6879(93)17065-d · Cited by 769
The selectins and their ligands
Rosen, S. D., & Bertozzi, C. R. (1994) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(94)90092-2 · Cited by 470
Siegelman, M. H., van de Rijn, M., & Weissman, I. L. (1989) · Science · doi:10.1126/science.2646713 · Cited by 420
Isolation of a highly specific ligand for the alpha 5 beta 1 integrin from a phage display library
Koivunen, E., Wang, B., & Ruoslahti, E. (1994) · The Journal of cell biology · doi:10.1083/jcb.124.3.373 · Cited by 308
Self-citationConsequences of angiogenesis for tumor progression, metastasis and cancer therapy
Rak, J. W., St Croix, B. D., & Kerbel, R. S. (1995) · Anti-Cancer Drugs · doi:10.1097/00001813-199502000-00001 · Cited by 243
Cited by
The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited
Fidler, I. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1098 · Cited by 4,686
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
Arap, W., Pasqualini, R., & Ruoslahti, E. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,054
Self-citationTumor angiogenesis: molecular pathways and therapeutic targets
Weis, S. M., & Cheresh, D. A. (2011) · Nature Medicine · doi:10.1038/nm.2537 · Cited by 1,736
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Kamaly, N., Xiao, Z., Valencia, P. M., Radovic-Moreno, A. F., & Farokhzad, O. C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15344k · Cited by 1,730
Smith, G. P., & Petrenko, V. A. (1997) · Chemical Reviews · doi:10.1021/cr960065d · Cited by 1,548
Åkerman, M. E., Chan, W. C. W., Laakkonen, P., Bhatia, S. N., & Ruoslahti, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152463399 · Cited by 1,437
Self-citationAnselmo, A. C., & Mitragotri, S. (2016) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10003 · Cited by 1,321
Nicolas, J., Mura, S., Brambilla, D., Mackiewicz, N., & Couvreur, P. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35265f · Cited by 1,270
In vivo molecular and cellular imaging with quantum dots
Gao, X., Yang, L., Petros, J. A., Marshall, F. F., Simons, J. W., & Nie, S. (2005) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2004.11.003 · Cited by 1,211
AACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective
Talmadge, J. E., & Fidler, I. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1040 · Cited by 1,169
Anti-cancer activity of targeted pro-apoptotic peptides
Ellerby, H. M., Arap, W., Ellerby, L. M., Kain, R., Andrusiak, R., Rio, G. D., Krajewski, S., Lombardo, C. R., Rao, R., Ruoslahti, E., et al. (1999) · Nature Medicine · doi:10.1038/12469 · Cited by 936
Self-citationMolecular mechanisms of cancer development in obesity
Khandekar, M. J., Cohen, P., & Spiegelman, B. M. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3174 · Cited by 907
Schiffelers, R. M. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh140 · Cited by 901
Targeting of drugs and nanoparticles to tumors
Ruoslahti, E., Bhatia, S. N., & Sailor, M. J. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200910104 · Cited by 829
Self-citationReview: Mesenchymal Stem Cells: Cell–Based Reconstructive Therapy in Orthopedics
Caplan, A. I. (2005) · Tissue Engineering · doi:10.1089/ten.2005.11.1198 · Cited by 822
αv Integrins as receptors for tumor targeting by circulating ligands
Pasqualini, R., Koivunen, E., & Ruoslahti, E. (1997) · Nature Biotechnology · doi:10.1038/nbt0697-542 · Cited by 744
Self-citationEndothelial Cell Heterogeneity
Aird, W. C. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006429 · Cited by 731
Current approaches in SELEX: An update to aptamer selection technology
Darmostuk, M., Rimpelova, S., Gbelcova, H., & Ruml, T. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.02.008 · Cited by 702
Defining the Hallmarks of Metastasis
Welch, D. R., & Hurst, D. R. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0458 · Cited by 700
Gelatinase-mediated migration and invasion of cancer cells
Björklund, M., & Koivunen, E. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.03.001 · Cited by 661
Steps toward mapping the human vasculature by phage display
Arap, W., Kolonin, M. G., Trepel, M., Lahdenranta, J., Cardó-Vila, M., Giordano, R. J., Mintz, P. J., Ardelt, P. U., Yao, V. J., Vidal, C. I., et al. (2002) · Nature Medicine · doi:10.1038/nm0202-121 · Cited by 607
Self-citationReversal of obesity by targeted ablation of adipose tissue
Kolonin, M. G., Saha, P. K., Chan, L., Pasqualini, R., & Arap, W. (2004) · Nature Medicine · doi:10.1038/nm1048 · Cited by 601
Self-citationViruses: Making Friends with Old Foes
Douglas, T., & Young, M. (2006) · Science · doi:10.1126/science.1123223 · Cited by 601
The importance of nanoparticle shape in cancer drug delivery
Truong, N. P., Whittaker, M. R., Mak, C. W., & Davis, T. P. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.950564 · Cited by 594
Self‐Assembled Peptide‐Based Nanomaterials for Biomedical Imaging and Therapy
Qi, G., Gao, Y., Wang, L., & Wang, H. (2018) · Advanced Materials · doi:10.1002/adma.201703444 · Cited by 527
Protein‐Based Nanomedicine Platforms for Drug Delivery
MaHam, A., Tang, Z., Wu, H., Wang, J., & Lin, Y. (2009) · Small · doi:10.1002/smll.200801602 · Cited by 524
Endothelial signaling during development
Cleaver, O., & Melton, D. A. (2003) · Nature Medicine · doi:10.1038/nm0603-661 · Cited by 517
Antibody phage display technology and its applications
Hoogenboom, H. R., de Bruı̈ne, A. P., Hufton, S. E., Hoet, R. M., Arends, J.-W., & Roovers, R. C. (1998) · Immunotechnology · doi:10.1016/s1380-2933(98)00007-4 · Cited by 512
Heterogeneity of Endothelial Cells: Specific Markers
Garlanda, C., & Dejana, E. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.7.1193 · Cited by 483
Oh, P., Li, Y., Yu, J., Durr, E., Krasinska, K. M., Carver, L. A., Testa, J. E., & Schnitzer, J. E. (2004) · Nature · doi:10.1038/nature02580 · Cited by 475
Biomimetic amplification of nanoparticle homing to tumors
Simberg, D., Duza, T., Park, J. H., Essler, M., Pilch, J., Zhang, L., Derfus, A. M., Yang, M., Hoffman, R. M., Bhatia, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610298104 · Cited by 471
Self-citationTumor penetrating peptides for improved drug delivery
Ruoslahti, E. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.03.008 · Cited by 459
Self-citationMolecular heterogeneity of the vascular endothelium revealed by in vivo phage display.
Rajotte, D., Arap, W., Hagedorn, M., Koivunen, E., Pasqualini, R., & Ruoslahti, E. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3008 · Cited by 457
Self-citationDetection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy
Hsiung, P.-L., Hardy, J., Friedland, S., Soetikno, R., Du, C. B., Wu, A. P., Sahbaie, P., Crawford, J. M., Lowe, A. W., Contag, C. H., et al. (2008) · Nature Medicine · doi:10.1038/nm1692 · Cited by 444
Durr, E., Yu, J., Krasinska, K. M., Carver, L. A., Yates, J. R., Testa, J. E., Oh, P., & Schnitzer, J. E. (2004) · Nature Biotechnology · doi:10.1038/nbt993 · Cited by 420
Peptides as Targeting Elements and Tissue Penetration Devices for Nanoparticles
Ruoslahti, E. (2012) · Advanced Materials · doi:10.1002/adma.201200454 · Cited by 419
Self-citationMüller, O. J., Kaul, F., Weitzman, M. D., Pasqualini, R., Arap, W., Kleinschmidt, J. A., & Trepel, M. (2003) · Nature Biotechnology · doi:10.1038/nbt856 · Cited by 410
Self-citationYusuf‐Makagiansar, H., Anderson, M. E., Yakovleva, T. V., Murray, J. S., & Siahaan, T. J. (2002) · Medicinal Research Reviews · doi:10.1002/med.10001 · Cited by 408
Biofunctional polymer nanoparticles for intra-articular targeting and retention in cartilage
Rothenfluh, D. A., Bermudez, H., O’Neil, C. P., & Hubbell, J. A. (2008) · Nature Materials · doi:10.1038/nmat2116 · Cited by 388
Metadherin, a cell surface protein in breast tumors that mediates lung metastasis
Brown, D. M., & Ruoslahti, E. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00079-0 · Cited by 385
Self-citationDesign of virus-based nanomaterials for medicine, biotechnology, and energy
Wen, A. M., & Steinmetz, N. F. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00287g · Cited by 379
Wang, Y.-X., Robertson, J. L., Spillman, W. B., & Claus, R. O. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000036909.41843.18 · Cited by 357
Phage display technology: clinical applications and recent innovations
Azzazy, H. M. E., & Highsmith, W. E. (2002) · Clinical Biochemistry · doi:10.1016/s0009-9120(02)00343-0 · Cited by 351
Strategies for the discovery and development of therapies for metastatic breast cancer
Eckhardt, B. L., Francis, P. A., Parker, B. S., & Anderson, R. L. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd2372 · Cited by 349
Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma
Agemy, L., Friedmann-Morvinski, D., Kotamraju, V. R., Roth, L., Sugahara, K. N., Girard, O. M., Mattrey, R. F., Verma, I. M., & Ruoslahti, E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114518108 · Cited by 347
Self-citationAdvancement and applications of peptide phage display technology in biomedical science
Wu, C.-H., Liu, I.-J., Lu, R.-M., & Wu, H.-C. (2016) · Journal of Biomedical Science · doi:10.1186/s12929-016-0223-x · Cited by 339
The biology of the combretastatins as tumour vascular targeting agents
TOZER, G. M., KANTHOU, C., PARKINS, C. S., & HILL, S. A. (2002) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2002.00211.x · Cited by 335
Fibronectin and Its Integrin Receptors in Cancer
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60772-1 · Cited by 330
Strategies to improve the EPR effect: A mechanistic perspective and clinical translation
Ikeda-Imafuku, M., Wang, L. L.-W., Rodrigues, D., Shaha, S., Zhao, Z., & Mitragotri, S. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.043 · Cited by 330
Endothelial cell heterogeneity
Aird, W. C. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000057847.32590.c1 · Cited by 324
Filamentous Bacteriophage: Biology, Phage Display and Nanotechnology Applications
(2011) · Current Issues in Molecular Biology · doi:10.21775/cimb.013.051 · Cited by 321
Orthotopic models of cancer for preclinical drug evaluation
Bibby, M. C. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.11.021 · Cited by 315
Antibody production, design and use for biosensor-based applications
Conroy, P. J., Hearty, S., Leonard, P., & O’Kennedy, R. J. (2009) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2009.01.010 · Cited by 314
Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival
Cieslewicz, M., Tang, J., Yu, J. L., Cao, H., Zavaljevski, M., Motoyama, K., Lieber, A., Raines, E. W., & Pun, S. H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312197110 · Cited by 314
Extracellular Matrix Cell Adhesion Peptides: Functional Applications in Orthopedic Materials
LeBaron, R. G., & Athanasiou, K. A. (2000) · Tissue Engineering · doi:10.1089/107632700320720 · Cited by 306
Oh, P., Borgström, P., Witkiewicz, H., Li, Y., Borgström, B. J., Chrastina, A., Iwata, K., Zinn, K. R., Baldwin, R., Testa, J. E., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1292 · Cited by 300
The Shape of Things to Come: Importance of Design in Nanotechnology for Drug Delivery
Liu, Y., Tan, J., Thomas, A., Ou-Yang, D., & Muzykantov, V. R. (2012) · Therapeutic Delivery · doi:10.4155/tde.11.156 · Cited by 299
Antibodies from phage antibody libraries
Bradbury, A. R. M., & Marks, J. D. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.04.007 · Cited by 296
Targeting the brain with PEG–PLGA nanoparticles modified with phage-displayed peptides
Li, J., Feng, L., Fan, L., Zha, Y., Guo, L., Zhang, Q., Chen, J., Pang, Z., Wang, Y., Jiang, X., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.031 · Cited by 296
Targeting the prostate for destruction through a vascular address
Arap, W., Haedicke, W., Bernasconi, M., Kain, R., Rajotte, D., Krajewski, S., Ellerby, H. M., Bredesen, D. E., Pasqualini, R., & Ruoslahti, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241655998 · Cited by 285
Self-citationM13-templated magnetic nanoparticles for targeted in vivo imaging of prostate cancer
Ghosh, D., Lee, Y., Thomas, S., Kohli, A. G., Yun, D. S., Belcher, A. M., & Kelly, K. A. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.146 · Cited by 284
Receptor mediated uptake of peptides that bind the human transferrin receptor
Lee, J. H., Engler, J. A., Collawn, J. F., & Moore, B. A. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02073.x · Cited by 280
Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles
Gao, H., Qian, J., Cao, S., Yang, Z., Pang, Z., Pan, S., Fan, L., Xi, Z., Jiang, X., & Zhang, Q. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.058 · Cited by 280
Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides
Dissanayake, S., Denny, W. A., Gamage, S., & Sarojini, V. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.02.006 · Cited by 280
Phage display screening of therapeutic peptide for cancer targeting and therapy
Saw, P. E., & Song, E.-W. (2019) · Protein & Cell · doi:10.1007/s13238-019-0639-7 · Cited by 279
Metastasis-Suppressor Genes: a Review and Perspective on an Emerging Field
Yoshida, B. A. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.21.1717 · Cited by 273
Display technologies: Application for the discovery of drug and gene delivery agents☆
SERGEEVA, A., KOLONIN, M., MOLLDREM, J., PASQUALINI, R., & ARAP, W. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.018 · Cited by 266
Self-citationMuruganandam, A., Tanha, J., Narang, S., & Stanimirovic, D. (2002) · The FASEB Journal · doi:10.1096/fj.01-0343fje · Cited by 260
Biodegradable, polymeric nanoparticle delivery systems for cancer therapy
Pridgen, E. M., Langer, R., & Farokhzad, O. C. (2007) · Nanomedicine · doi:10.2217/17435889.2.5.669 · Cited by 249
“These are short sequences of 5–10 amino acids that can be screened for using binding assays to target cells or tissues [84,85].”
BackgroundA Historical Review of Brain Drug Delivery
Pardridge, W. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061283 · Cited by 219
Joyce, J. A., Laakkonen, P., Bernasconi, M., Bergers, G., Ruoslahti, E., & Hanahan, D. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00271-x · Cited by 211
Self-citationCurrent Advances and Future Challenges in Adenoviral Vector Biology and Targeting
Campos, S., & Barry, M. (2007) · Current Gene Therapy · doi:10.2174/156652307780859062 · Cited by 210
Lien, S., & Lowman, H. B. (2003) · Trends in Biotechnology · doi:10.1016/j.tibtech.2003.10.005 · Cited by 209
Targeting tumor vasculature with homing peptides from phage display
Ruoslahti, E. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0334 · Cited by 157
Self-citationThe in vivo endothelial cell translatome is highly heterogeneous across vascular beds
Cleuren, A. C. A., van der Ent, M. A., Jiang, H., Hunker, K. L., Yee, A., Siemieniak, D. R., Molema, G., Aird, W. C., Ganesh, S. K., & Ginsburg, D. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912409116 · Cited by 152
High-Throughput Discovery of Synthetic Surfaces That Support Proliferation of Pluripotent Cells
Derda, R., Musah, S., Orner, B. P., Klim, J. R., Li, L., & Kiessling, L. L. (2010) · Journal of the American Chemical Society · doi:10.1021/ja906089g · Cited by 144
Peptides as drug delivery vehicles across biological barriers
Ghosh, D., Peng, X., Leal, J., & Mohanty, R. P. (2018) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-017-0374-0 · Cited by 102
In vitro models of the metastatic cascade: from local invasion to extravasation
Bersini, S., Jeon, J. S., Moretti, M., & Kamm, R. D. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2013.12.006 · Cited by 71
“Endothelial cells in the vasculature of different organs express different surface receptors and specific chemokines are secreted by host cells of individual tissues [31,32].”
BackgroundBacteriophage Therapy: Discovery, Development, and FDA Approval Pathways
Niazi, S. K. (2025) · Pharmaceuticals · doi:10.3390/ph18081115 · Cited by 56
Tumor cells-specific targeting delivery achieved by A54 peptide functionalized polymeric micelles
Du, Y.-Z., Cai, L.-L., Liu, P., You, J., Yuan, H., & Hu, F.-Q. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.08.043 · Cited by 54
Generation of peptides using phage display technology for cancer diagnosis and molecular imaging
Pung, H. S., Tye, G. J., Leow, C. H., Ng, W. K., & Lai, N. S. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08380-x · Cited by 30
Zhang, X., Chai, Z., Lee Dobbins, A., Itano, M. S., Askew, C., Miao, Z., Niu, H., Samulski, R. J., & Li, C. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2021.121340 · Cited by 23
A peptide targeting inflammatory CNS lesions in the EAE rat model of multiple sclerosis
Boiziau, C., Nikolski, M., Mordelet, E., Aussudre, J., Vargas-Sanchez, K., & Petry, K. G. (2018) · Inflammation · doi:10.1007/s10753-018-0748-0 · Cited by 10
Sekar, T. V., Elghonaimy, E. A., Swancutt, K. L., Diegeler, S., Gonzalez, I., Hamilton, C., Leung, P. Q., Meiler, J., Martina, C. E., Whitney, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43038-z · Cited by 8
Metadata
- Authors
- Pasqualini, R., & Ruoslahti, E.
- Venue
- Nature
- Published
- 1996-03
- Volume
- 380
- Issue
- 6572
- Pages
- 364-366
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1998162097
- Cited by
- 1,221
- References
- 15
- FWCI
- 24.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.